Nanomedicine in cancer therapy: Innovative trends and prospects

Cancer is a leading cause of morbidity and mortality worldwide, with recent advancements resulting in modest impacts on patient survival. Nanomedicine represents an innovative field with immense potential for improving cancer treatment, having ushered in several established drug delivery platforms....

Full description

Saved in:
Bibliographic Details
Published in:Cancer science 2011-07, Vol.102 (7), p.1247-1252
Main Authors: Blanco, Elvin, Hsiao, Angela, Mann, Aman P., Landry, Matthew G., Meric‐Bernstam, Funda, Ferrari, Mauro
Format: Article
Language:English
Subjects:
Animals
Antineoplastic Agents - administration & dosage
Biological and medical sciences
Delayed-Action Preparations
Dendrimers
Drug Carriers
Drug Delivery Systems
Humans
Liposomes
Medical sciences
Micelles
Nanomedicine
Nanoparticles
Neoplasms - drug therapy
Review
Tumors
Citations: Items that this one cites
Items that cite this one
Online Access:Request full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Cancer is a leading cause of morbidity and mortality worldwide, with recent advancements resulting in modest impacts on patient survival. Nanomedicine represents an innovative field with immense potential for improving cancer treatment, having ushered in several established drug delivery platforms. Nanoconstructs such as liposomes are widely used in clinics, while polymer micelles are in advanced phases of clinical trials in several countries. Currently, the field of nanomedicine is generating a new wave of nanoscale drug delivery strategies, embracing trends that involve the functionalization of these constructs with moieties that enhance site‐specific delivery and tailored release. Herein, we discuss several advancements in established nanoparticle technologies such as liposomes, polymer micelles, and dendrimers regarding tumor targeting and controlled release strategies, which are being incorporated into their design with the hope of generating a more robust and efficacious nanotherapeutic modality. We also highlight a novel strategy known as multistage drug delivery; a rationally designed nanocarrier aimed at overcoming numerous biological barriers involved in drug delivery through the decoupling of various tasks that comprise the journey from the moment of systemic administration to arrival at the tumor site. (Cancer Sci 2011; 102: 1247–1252)
ISSN:1347-9032
1349-7006
1349-7006
DOI:10.1111/j.1349-7006.2011.01941.x